A recently completed study indicates that circulatory protein levels can provide important information for increasingly accurate diagnoses and personalised care in patients with aggressive B-cell ...
Hi, my name is Deborah Stephens and I'm a physician and a researcher at the Huntsman Cancer Institute. And I'm here today to answer questions about blood cancer, and more specifically, questions about ...
CORALVILLE, Iowa--(BUSINESS WIRE)-- Integrated DNA Technologies, a global leader in genomics solutions, proudly announces the expansion of its Archer™ next-generation sequencing (NGS) assay solutions ...
RYE BROOK, N.Y. & SEATTLE--(BUSINESS WIRE)--The Leukemia & Lymphoma Society® (LLS), a global leader in the fight against blood cancer, and Tasso, Inc., the leading provider of patient-centric, ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.
B-cell lymphoma is the most common cancer of the lymphatic system. In roughly 30% of patients with aggressive B-cell lymphoma, the disease relapses. At the moment, risk profiling for the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results